Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2018-04-04 2018-03-26
Drug Identification Number 02436221 02436221
Brand name LIDOCAINE 2% AND EPINEPHRINE 1:100,000 INJECTION LIDOCAINE 2% AND EPINEPHRINE 1:100,000 INJECTION
Common or Proper name LIDOCAINE AND EPINEPHRINE INJECTION LIDOCAINE AND EPINEPHRINE INJECTION
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients LIDOCAINE HYDROCHLORIDE EPINEPHRINE LIDOCAINE HYDROCHLORIDE EPINEPHRINE
Strength(s) 20MG 0.01MG 20MG 0.01MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging size 50 ML 50 ML
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-03-07 2018-03-07
Estimated end date 2018-05-01 2018-05-01
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments